Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix.

Kanapathipillai M, Mammoto A, Mammoto T, Kang JH, Jiang E, Ghosh K, Korin N, Gibbs A, Mannix R, Ingber DE.

Nano Lett. 2012 Jun 13;12(6):3213-7. doi: 10.1021/nl301206p. Epub 2012 May 10.

PMID:
22554317
2.

Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells.

Saad FA, Torres M, Wang H, Graham L.

Biochem Biophys Res Commun. 2010 Jun 11;396(4):944-9. doi: 10.1016/j.bbrc.2010.05.028. Epub 2010 May 9.

PMID:
20460108
3.

The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.

Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, Trackman PC, Sonenshein GE.

Cancer Res. 2007 Feb 1;67(3):1105-12.

4.

The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.

Pez F, Dayan F, Durivault J, Kaniewski B, Aimond G, Le Provost GS, Deux B, Clézardin P, Sommer P, Pouysségur J, Reynaud C.

Cancer Res. 2011 Mar 1;71(5):1647-57. doi: 10.1158/0008-5472.CAN-10-1516. Epub 2011 Jan 14.

5.

A molecular role for lysyl oxidase in breast cancer invasion.

Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ.

Cancer Res. 2002 Aug 1;62(15):4478-83.

6.

Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.

Mercier N, Kakou A, Challande P, Lacolley P, Osborne-Pellegrin M.

Toxicol Appl Pharmacol. 2009 Sep 15;239(3):258-67. doi: 10.1016/j.taap.2009.06.005. Epub 2009 Jun 12.

PMID:
19524603
7.

Lysyl oxidase: from basic science to future cancer treatment.

Nishioka T, Eustace A, West C.

Cell Struct Funct. 2012;37(1):75-80. Review.

8.

Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.

Laczko R, Szauter KM, Jansen MK, Hollosi P, Muranyi M, Molnar J, Fong KS, Hinek A, Csiszar K.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):631-43. Epub 2007 Oct 11.

PMID:
17931358
9.

Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts.

Bouclier C, Marsaud V, Bawa O, Nicolas V, Moine L, Opolon P, Renoir JM.

Breast Cancer Res Treat. 2010 Jul;122(1):145-58. doi: 10.1007/s10549-009-0558-z. Epub 2009 Sep 22.

PMID:
19771505
10.

Drosophila lysyl oxidases Dmloxl-1 and Dmloxl-2 are differentially expressed and the active DmLOXL-1 influences gene expression and development.

Molnar J, Ujfaludi Z, Fong SF, Bollinger JA, Waro G, Fogelgren B, Dooley DM, Mink M, Csiszar K.

J Biol Chem. 2005 Jun 17;280(24):22977-85. Epub 2005 Apr 4.

11.

Paradoxical roles for lysyl oxidases in cancer--a prospect.

Payne SL, Hendrix MJ, Kirschmann DA.

J Cell Biochem. 2007 Aug 15;101(6):1338-54. Review.

PMID:
17471532
12.

Effect of Semecarpus anacardium nut extract on ECM and proteases in mammary carcinoma rats.

Mathivadhani P, Shanthi P, Sachdanandam P.

Vascul Pharmacol. 2007 Jun;46(6):419-26. Epub 2007 Jan 13.

PMID:
17337360
13.

Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells.

Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S, Svasti J, Saiki I.

Eur J Pharm Sci. 2005 May;25(1):57-65.

PMID:
15854801
15.

Lysyl oxidase as a potential therapeutic target.

Rodríguez C, Rodríguez-Sinovas A, Martínez-González J.

Drug News Perspect. 2008 May;21(4):218-24. doi: 10.1358/dnp.2008.21.4.1213351. Review.

PMID:
18560621
16.

Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP.

Clin Cancer Res. 2006 Apr 15;12(8):2613-21.

17.

Lysyl oxidase: an oxidative enzyme and effector of cell function.

Lucero HA, Kagan HM.

Cell Mol Life Sci. 2006 Oct;63(19-20):2304-16. Review.

PMID:
16909208
18.
19.

Lysyl oxidase in development, aging and pathologies of the skin.

Szauter KM, Cao T, Boyd CD, Csiszar K.

Pathol Biol (Paris). 2005 Sep;53(7):448-56.

PMID:
16085123
20.

The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers.

Thomassin L, Werneck CC, Broekelmann TJ, Gleyzal C, Hornstra IK, Mecham RP, Sommer P.

J Biol Chem. 2005 Dec 30;280(52):42848-55. Epub 2005 Oct 26.

Supplemental Content

Support Center